---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-097657"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:00:07.377416+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BD completes spinoff of Diabetes Care business as Embecta Corp. (EMBC)

## Summary
- Shareholders receive one share of embecta for every five BD shares held as of March 22, 2022.
- BD retains no ownership; embecta begins trading on NASDAQ under ticker EMBC.
- Two BD directors (Claire Pomeroy, David Melcher) resign to join embecta board; BD board reduced to 11.
- embecta issued $200M 6.750% senior secured notes due 2030 to BD; BD exchanged for $199M floating-rate notes.
- BD guaranteed embecta credit facility and senior notes; guarantee automatically released upon separation.

## SEC filing metadata
- accession: 0001193125-22-097657
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/0001193125-22-097657-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/d328383d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-097657
- JSON: https://secwatch.observer/filing/0001193125-22-097657.json
- Plain text: https://secwatch.observer/filing/0001193125-22-097657.txt

## Key facts
- Executive change
  Claire Pomeroy resigned as director at BECTON DICKINSON & CO.
  - Action: resigned
  - Role: director
  source text: each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/0001193125-22-097657-index.htm
- Executive change
  David Melcher resigned as director at BECTON DICKINSON & CO.
  - Action: resigned
  - Role: director
  source text: each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000119312522097657/0001193125-22-097657-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.